FDA Approved: ANCOBON — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

FDA approved a supplemental application for ANCOBON (flucytosine) submitted by Bausch Health US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Infections
• Cryptococcal Meningitis

Drugs mentioned

• ANCOBON (Flucytosine)

Snippet

SUPPL AP for ANCOBON (FLUCYTOSINE)